624 related articles for article (PubMed ID: 30862232)
1. Sex-specific clinical outcomes of impaired glucose status: A long follow-up from the Tehran Lipid and Glucose Study.
Parizadeh D; Rahimian N; Akbarpour S; Azizi F; Hadaegh F
Eur J Prev Cardiol; 2019 Jul; 26(10):1080-1091. PubMed ID: 30862232
[TBL] [Abstract][Full Text] [Related]
2. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
[TBL] [Abstract][Full Text] [Related]
3. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis.
Huang Y; Cai X; Mai W; Li M; Hu Y
BMJ; 2016 Nov; 355():i5953. PubMed ID: 27881363
[TBL] [Abstract][Full Text] [Related]
4. Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study.
Warren B; Pankow JS; Matsushita K; Punjabi NM; Daya NR; Grams M; Woodward M; Selvin E
Lancet Diabetes Endocrinol; 2017 Jan; 5(1):34-42. PubMed ID: 27863979
[TBL] [Abstract][Full Text] [Related]
5. Relationship of hyperinsulinaemia, insulin resistance and β-cell dysfunction with incident diabetes and pre-diabetes: the Tehran Lipid and Glucose Study.
Derakhshan A; Tohidi M; Arshi B; Khalili D; Azizi F; Hadaegh F
Diabet Med; 2015 Jan; 32(1):24-32. PubMed ID: 25131451
[TBL] [Abstract][Full Text] [Related]
6. Sex-specific prevalence of coronary heart disease among Tehranian adult population across different glycemic status: Tehran lipid and glucose study, 2008-2011.
Moazzeni SS; Ghafelehbashi H; Hasheminia M; Parizadeh D; Ghanbarian A; Azizi F; Hadaegh F
BMC Public Health; 2020 Oct; 20(1):1510. PubMed ID: 33023566
[TBL] [Abstract][Full Text] [Related]
7. The association between fasting plasma glucose and glycated hemoglobin in the prediabetes range and future development of hypertension.
Geva M; Shlomai G; Berkovich A; Maor E; Leibowitz A; Tenenbaum A; Grossman E
Cardiovasc Diabetol; 2019 Apr; 18(1):53. PubMed ID: 31029146
[TBL] [Abstract][Full Text] [Related]
8. Association between prediabetes (defined by HbA1
Kim GS; Oh HH; Kim SH; Kim BO; Byun YS
BMC Nephrol; 2019 Apr; 20(1):130. PubMed ID: 30992067
[TBL] [Abstract][Full Text] [Related]
9. Different Combinations of Glucose Tolerance and Blood Pressure Status and Incident Diabetes, Hypertension, and Chronic Kidney Disease.
Derakhshan A; Bagherzadeh-Khiabani F; Arshi B; Ramezankhani A; Azizi F; Hadaegh F
J Am Heart Assoc; 2016 Aug; 5(8):. PubMed ID: 27543801
[TBL] [Abstract][Full Text] [Related]
10. Normal fasting plasma glucose and risk of prediabetes and type 2 diabetes: the Isfahan Diabetes Prevention Study.
Janghorbani M; Amini M
Rev Diabet Stud; 2011; 8(4):490-8. PubMed ID: 22580730
[TBL] [Abstract][Full Text] [Related]
11. Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.
Richter B; Hemmingsen B; Metzendorf MI; Takwoingi Y
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012661. PubMed ID: 30371961
[TBL] [Abstract][Full Text] [Related]
12. Three-year change in glycemic state and the future risk of incident hypertension among Iranian adults: Tehran Lipid and Glucose Study.
Moazzeni SS; Dehghani S; Hasheminia M; Hizomi Arani R; Azizi F; Hadaegh F
J Hum Hypertens; 2023 Oct; 37(10):944-949. PubMed ID: 36473941
[TBL] [Abstract][Full Text] [Related]
13. Identification of impaired fasting glucose, healthcare utilization and progression to diabetes in the UK using the Clinical Practice Research Datalink (CPRD).
Hong JL; McNeill AM; He J; Chen Y; Brodovicz KG
Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1375-1386. PubMed ID: 27193175
[TBL] [Abstract][Full Text] [Related]
14. Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis.
Cai X; Zhang Y; Li M; Wu JH; Mai L; Li J; Yang Y; Hu Y; Huang Y
BMJ; 2020 Jul; 370():m2297. PubMed ID: 32669282
[TBL] [Abstract][Full Text] [Related]
15. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
Levitzky YS; Pencina MJ; D'Agostino RB; Meigs JB; Murabito JM; Vasan RS; Fox CS
J Am Coll Cardiol; 2008 Jan; 51(3):264-70. PubMed ID: 18206734
[TBL] [Abstract][Full Text] [Related]
16. Associations of prediabetes with all-cause and cardiovascular mortality: a meta-analysis.
Huang Y; Cai X; Chen P; Mai W; Tang H; Huang Y; Hu Y
Ann Med; 2014 Dec; 46(8):684-92. PubMed ID: 25230915
[TBL] [Abstract][Full Text] [Related]
17. Long term prognostic implication of newly detected abnormal glucose tolerance among patients with stable cardiovascular disease: a population-based cohort study.
Kabootari M; Asgari S; Ghavam SM; Abdi H; Azizi F; Hadaegh F
J Transl Med; 2021 Jun; 19(1):277. PubMed ID: 34193200
[TBL] [Abstract][Full Text] [Related]
18. Increased Vascular Disease Mortality Risk in Prediabetic Korean Adults Is Mainly Attributable to Ischemic Stroke.
Kim NH; Kwon TY; Yu S; Kim NH; Choi KM; Baik SH; Park Y; Kim SG
Stroke; 2017 Apr; 48(4):840-845. PubMed ID: 28258257
[TBL] [Abstract][Full Text] [Related]
19. Role of various indices derived from an oral glucose tolerance test in the prediction of conversion from prediabetes to type 2 diabetes.
Kim YA; Ku EJ; Khang AR; Hong ES; Kim KM; Moon JH; Choi SH; Park KS; Jang HC; Lim S
Diabetes Res Clin Pract; 2014 Nov; 106(2):351-9. PubMed ID: 25245975
[TBL] [Abstract][Full Text] [Related]
20. Fasting plasma glucose as initial screening for diabetes and prediabetes in irish adults: The Diabetes Mellitus and Vascular health initiative (DMVhi).
Sinnott M; Kinsley BT; Jackson AD; Walsh C; O'Grady T; Nolan JJ; Gaffney P; Boran G; Kelleher C; Carr B
PLoS One; 2015; 10(4):e0122704. PubMed ID: 25874867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
